ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CARLOS MARILL M.D., P.A.

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,502Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 1290

$638K Total Retail Price of All Prescriptions

Rank: 124 out of 1290

401 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 12,450 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $94 among peers.

Prescriptions per Patient

34 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 518 482 1 1
LEVOTHYROXINE SODIUM 482 452 2 4
AMLODIPINE BESYLATE 463 429 3 3
OMEPRAZOLE 438 382 4 2
METFORMIN HCL 399 380 5 10
CRESTOR 391 365 6 17
LOSARTAN POTASSIUM 364 338 7 19
SERTRALINE HCL 325 312 8 36
ALPRAZOLAM 325 293 8 47
AMLODIPINE BESYLATE-BENAZEPRIL 258 256 10 166
ATORVASTATIN CALCIUM 257 236 11 23
DONEPEZIL HCL 229 229 12 13
HYDROCHLOROTHIAZIDE 217 194 13 20
RANITIDINE HCL 216 196 14 49
METOPROLOL SUCCINATE 212 208 15 14
LISINOPRIL 205 188 16 5
ATENOLOL 192 178 17 18
ZOLPIDEM TARTRATE 191 165 18 15
DIOVAN 177 144 19 53
DICLOFENAC POTASSIUM 166 151 20 321
METOPROLOL TARTRATE 162 146 21 7
JANUVIA 160 143 22 82
PANTOPRAZOLE SODIUM 150 141 23 48
DIOVAN HCT 147 145 24 112
NEXIUM 141 134 25 34
CLOPIDOGREL 138 126 26 24
BYSTOLIC 136 136 27 251
ALENDRONATE SODIUM 126 126 28 39
PLAVIX 125 120 29 32
TAMSULOSIN HCL 124 112 30 11
SYNTHROID 122 112 31 28
PRAVASTATIN SODIUM 120 105 32 42
WARFARIN SODIUM 117 117 33 22
TRAMADOL HCL 110 77 34 25
GLYBURIDE-METFORMIN HCL 99 99 R 35 147
FUROSEMIDE 98 87 36 9
AZITHROMYCIN 95 86 37 61
CLOTRIMAZOLE-BETAMETHASONE 92 80 38 153
ESCITALOPRAM OXALATE 85 75 39 63
ALLOPURINOL 83 83 40 60
CIPROFLOXACIN HCL 78 68 41 46
QUINAPRIL HCL 76 76 42 459
LOVASTATIN 73 67 43 45
ROPINIROLE HCL 70 60 44 146
POTASSIUM CHLORIDE 70 61 44 35
LORAZEPAM 70 59 44 132
LANSOPRAZOLE 70 70 44 181
LEVOFLOXACIN 68 59 48 150
LOSARTAN-HYDROCHLOROTHIAZIDE 65 60 49 106
TEMAZEPAM 65 52 49 71
CYMBALTA 61 49 51 59
TRIAMTERENE-HCTZ 61 61 51 130
GLIMEPIRIDE 58 58 53 57
CARVEDILOL 57 43 54 12
JANUMET 55 55 55 217
MECLIZINE HCL 54 51 56 159
LABETALOL HCL 53 53 57 217
VIAGRA 53 52 57 124
BENICAR 53 53 57 205
BISOPROLOL-HYDROCHLOROTHIAZIDE 52 52 60 357
LIPITOR 51 51 61 195
AVODART 51 51 61 69
PAROXETINE HCL 51 51 61 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 26, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.